bankruptcy

Rite Aid’s plan to close more stores as part of its bankruptcy process raises concern about how that might hurt access to medicine and care.

Rite Aid has been weighed down by billions in debt, declining sales and more than a 1,000 federal, state and local lawsuits claiming it filled hundreds of thousands of illegal prescriptions for painkillers.

Supreme Court's decision to review the controversial bankruptcy deal involving the maker of Oxycontin means the settlement will remain on hold at least through December.

Medical bills are a leading reason people get stuck in a cycle of debt. The nonprofit Upsolve created an app it calls the “TurboTax of bankruptcy” to help people hit reset and rebuild their financial lives.

A federal judge has overturned a bankruptcy settlement worth more than $4 billion that granted immunity from opioid lawsuits to members of the family who owns the company that makes OxyContin.

Judge Colleen McMahon was expected to halt work on the controversial settlement that would give immunity from opioid lawsuits to the Sackler family. Instead she allowed work on the plan to go ahead.

The DOJ is seeking to block implementation of any part of the Purdue Pharma bankruptcy deal until legal challenges are settled. The deal granted Sackler family members immunity from opioid lawsuits.

The decision by a federal bankruptcy judge grants members of the family who own Purdue Pharma, maker of OxyContin, sweeping protection from any liability for the opioid crisis.

With a federal judge poised to approve Purdue Pharma's controversial Chapter 11 plan, the company is working behind the scenes to preempt a legal challenge by the Justice Department.

Two divisions of the DOJ argue the deal improperly shelters members of the Sackler family and their associates from liability. States are finalizing a separate deal with other opioid companies.